CLINICAL complete response (cCR) is a strong predictor of prognosis in patients with unresectable hepatocellular carcinoma ...

Delcath Systems, Inc. (Nasdaq: DCTH) ("Delcath" or the "Company"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced an update ...

Amezalpat has been granted FDA fast track designation as treatment for patients with hepatocellular carcinoma.

KAMPALA - People living in Kampala are at a high risk of developing lung cancer due to severe air pollution, health experts have warned. ;The experts said the air quality in Kampala is worse compared ...

Liver, and head and neck cancers are more prevalent in Asia, highlighting the need for improved understanding and treatment options here.

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new ...

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential with other cancers as well.

Investigator Award has been awarded to two surgeon-scientists at the National Cancer Centre Singapore (NCCS) to pursue novel research in liver cancer and head and neck cancers. Globally, liver cancer ...

The decline in cancer incidence among men and increase among women has narrowed the male‐to-female cancer incidence rate ratio from a peak of 1.6 in 1992 to 1.1 in 2021. In people aged 50-64 years, ...

Frontline treatment with Tevimbra plus irinotecan, paclitaxel, oxaliplatin and 5-FU/leucovorin had promising efficacy and ...

In a groundbreaking medical achievement in the U.K., a 32-year-old woman from Manchester has undergone the country's first ...